Paediatrics Publications
Response to the Canadian Agency for Drugs and Technologies in Health and Institut national d'excellence en santé et en services sociaux decision regarding nusinersen for Spinal Muscular Atrophy.
Document Type
Article
Publication Date
9-1-2018
Journal
The Canadian Journal of Neurological Sciences / Le Journal Canadien des Sciences Neurologiques
Volume
45
Issue
5
First Page
516
Last Page
517
URL with Digital Object Identifier
https://doi.org/10.1017/cjn.2018.59
Notes
Article available at The Canadian Journal of Neurological Sciences / Le Journal Canadien des Sciences Neurologiques
https://doi.org/10.1017/cjn.2018.59
All authors contributed equally to the creation of this statement.
© 2018 The Canadian Journal of Neurological Sciences Inc.